Core Laboratories Inc. (NYSE:CLB) Position Reduced by Natixis Advisors LLC

Natixis Advisors LLC trimmed its stake in shares of Core Laboratories Inc. (NYSE:CLB) by 4.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,182 shares of the oil and gas company’s stock after selling 559 shares during the quarter. Natixis Advisors LLC’s holdings in Core Laboratories were worth $207,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Core Laboratories by 0.5% during the first quarter. Vanguard Group Inc. now owns 5,392,034 shares of the oil and gas company’s stock worth $92,096,000 after purchasing an additional 27,701 shares during the period. Disciplined Growth Investors Inc. MN raised its holdings in shares of Core Laboratories by 446.8% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company’s stock worth $90,508,000 after purchasing an additional 3,644,963 shares during the period. Earnest Partners LLC raised its holdings in shares of Core Laboratories by 6.3% during the second quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after purchasing an additional 195,756 shares during the period. Royce & Associates LP raised its holdings in shares of Core Laboratories by 9.0% during the third quarter. Royce & Associates LP now owns 1,021,121 shares of the oil and gas company’s stock worth $18,921,000 after purchasing an additional 84,022 shares during the period. Finally, Boston Trust Walden Corp raised its holdings in shares of Core Laboratories by 1.3% during the second quarter. Boston Trust Walden Corp now owns 729,760 shares of the oil and gas company’s stock worth $14,807,000 after purchasing an additional 9,468 shares during the period. 97.81% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CLB has been the topic of a number of analyst reports. Citigroup dropped their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a report on Thursday, October 31st. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.00.

Core Laboratories Stock Down 0.2 %

CLB stock opened at $20.37 on Friday. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. Core Laboratories Inc. has a fifty-two week low of $13.82 and a fifty-two week high of $25.13. The firm’s 50-day simple moving average is $19.46 and its 200 day simple moving average is $19.53. The stock has a market cap of $956.37 million, a PE ratio of 31.34, a price-to-earnings-growth ratio of 1.37 and a beta of 2.35.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.21 by $0.04. The firm had revenue of $134.40 million for the quarter, compared to analysts’ expectations of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. Core Laboratories’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company earned $0.22 EPS. As a group, sell-side analysts predict that Core Laboratories Inc. will post 0.8 EPS for the current year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a dividend of $0.01 per share. The ex-dividend date was Monday, November 4th. This represents a $0.04 annualized dividend and a yield of 0.20%. Core Laboratories’s payout ratio is 6.15%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.